Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    - The page revision label was updated to v3.5.4, replacing the previous v3.5.3 and signaling a minor update to the page without changing its study details.
    Difference
    0.1%
    Check dated 2026-05-14T22:55:35.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.2 to v3.5.3, representing a new version of the study record. This change signals a minor update to the page's versioning without altering the substantive study information.
    Difference
    0.1%
    Check dated 2026-04-30T16:36:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed, updating the page's version metadata without changes to the core study details.
    Difference
    0.1%
    Check dated 2026-04-16T10:04:03.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version updated from v3.4.3 to v3.5.0 on the page, indicating a platform-level update without changes to study data or content.
    Difference
    0.1%
    Check dated 2026-03-18T16:59:14.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2 in the revision history.
    Difference
    0.1%
    Check dated 2026-03-11T16:39:40.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Results section updated with data on dose-limiting toxicities, timing, and RECIST responses. Exploratory biomarker endpoints were removed.
    Difference
    3%
    Check dated 2026-02-18T04:24:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.